Opaleye Management Inc. Chimerix Inc Transaction History

Opaleye Management Inc.

$390 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $1.93 Million - $2.94 Million	-1,065,000 Reduced 74.48%	365,000 $704,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $5.99 Million - $23.9 Million	-4,473,450 Reduced 75.78%	1,430,000 $2.97 Million
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $1.48 Million - $2.2 Million	323,450 Added 5.8%	5,903,450 $27 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $2.88 Million - $3.95 Million	550,000 Added 10.93%	5,580,000 $35.9 Million
Q3 2021 Nov 16, 2021	BUY	$5.94 - $8.75 $2.38 Million - $3.5 Million	400,000 Added 8.64%	5,030,000 $31.1 Million
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $1.06 Million - $1.37 Million	140,000 Added 3.12%	4,630,000 $37 Million
Q1 2021 May 18, 2021	BUY	$4.76 - $11.25 $2.54 Million - $6 Million	533,500 Added 13.48%	4,490,000 $43.3 Million
Q4 2020 Feb 12, 2021	BUY	$2.43 - $5.42 $279,450 - $623,300	115,000 Added 2.99%	3,956,500 $19.1 Million
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $3.99 Million - $6.46 Million	1,736,500 Added 82.49%	3,841,500 $9.57 Million
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $2.8 Million - $7.64 Million	2,105,000 New	2,105,000 $6.53 Million
Q3 2019 Nov 14, 2019	SELL	$1.93 - $4.21 $2.84 Million - $6.19 Million	-1,470,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.05 - $4.32 $1.05 Million - $2.2 Million	510,000 Added 53.13%	1,470,000 $6.35 Million
Q1 2019 May 15, 2019	SELL	$1.79 - $3.12 $1.9 Million - $3.31 Million	-1,060,000 Reduced 52.48%	960,000 $2.02 Million
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $1.87 Million - $3.26 Million	835,000 Added 70.46%	2,020,000 $5.19 Million
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $125,300 - $171,500	35,000 Added 3.04%	1,185,000 $4.61 Million
Q2 2018 Aug 14, 2018	BUY	$4.43 - $5.14 $2.44 Million - $2.83 Million	550,000 Added 91.67%	1,150,000 $5.47 Million
Q4 2017 Feb 09, 2018	SELL	$4.32 - $5.52 $3.47 Million - $4.43 Million	-803,000 Reduced 57.23%	600,000 $2.78 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $6.1 Million - $7.37 Million	1,403,000	1,403,000 $7.37 Million

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Account